NYSE - Delayed Quote USD

Tenet Healthcare Corporation (THC)

93.19 +2.11 (+2.32%)
At close: 4:00 PM EDT
93.00 -0.19 (-0.20%)
After hours: 5:57 PM EDT
Loading Chart for THC
DELL
  • Previous Close 91.08
  • Open 91.38
  • Bid --
  • Ask --
  • Day's Range 91.71 - 93.52
  • 52 Week Range 51.04 - 107.80
  • Volume 1,127,374
  • Avg. Volume 1,166,187
  • Market Cap (intraday) 9.243B
  • Beta (5Y Monthly) 2.14
  • PE Ratio (TTM) 16.32
  • EPS (TTM) 5.71
  • Earnings Date Apr 30, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 13, 2000
  • 1y Target Est --

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

www.tenethealth.com

78,810

Full Time Employees

December 31

Fiscal Year Ends

Recent News: THC

Performance Overview: THC

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

THC
23.32%
S&P 500
4.14%

1-Year Return

THC
40.47%
S&P 500
19.55%

3-Year Return

THC
71.24%
S&P 500
18.68%

5-Year Return

THC
298.08%
S&P 500
70.99%

Compare To: THC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: THC

Valuation Measures

As of 4/18/2024
  • Market Cap

    9.03B

  • Enterprise Value

    22.81B

  • Trailing P/E

    15.95

  • Forward P/E

    14.39

  • PEG Ratio (5yr expected)

    2.00

  • Price/Sales (ttm)

    0.46

  • Price/Book (mrq)

    5.62

  • Enterprise Value/Revenue

    1.11

  • Enterprise Value/EBITDA

    6.73

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.97%

  • Return on Assets (ttm)

    6.28%

  • Return on Equity (ttm)

    25.92%

  • Revenue (ttm)

    20.55B

  • Net Income Avi to Common (ttm)

    611M

  • Diluted EPS (ttm)

    5.71

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.23B

  • Total Debt/Equity (mrq)

    294.35%

  • Levered Free Cash Flow (ttm)

    893M

Research Analysis: THC

Fair Value

Near Fair Value
% Return
93.19 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Research Reports: THC

  • THC: Lowering target price to $103.00

    TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $103.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Neutral
    Price Target
     
  • THC: Lowering target price to $107.00

    TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $107.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Neutral
    Price Target
     
  • THC: Raising target price to $108.00

    TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $108.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Neutral
    Price Target
     
  • THC: Lowering target price to $107.00

    TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $107.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Neutral
    Price Target
     

People Also Watch